References Paclitaxel Premedication Regimens Page 1 This opinion is based on our recent
analysis of 879 consecutive patients referred with suspected MUO. These patients were …

The Canadian Real-world Evidence for Value in Cancer Drugs (CanREValue) Collaboration
was established to develop a framework for generating and using real-world evidence (…

Objectives Treatment of advanced NSCLC (aNSCLC) is rapidly evolving, as new targeted
and immuno-oncology (IO) treatments become available. The iTEN model was developed to …

Multi-criteria decision analysis (MCDA) is a value assessment tool designed to help support
complex decision-making by incorporating multiple factors and perspectives in a transparent…

Background: Expenditure on systemic therapy for cancer has been increasing quickly owing
to population growth, increased use, both in the number of users and in prescription volume…

Treatment of Cavernous Hemangioma with Vincristine - Darryl K. Boehm, Nathan L.
Kobrinsky, 1993 …

We appreciate the very thoughtful comments on the iTEN model by Goffin [1], and the
shared interest in the use of modeling to better inform policymakers in assessing emerging …

ABSTRACT A retrospective chart review was conducted to evaluate a set of equations which
use a patient's creatinine clearance (CrCI), body surface area, pretreatment platelet count, …

It is current only as of the date listed on the Drug Formulary, and is not intended to constitute
medical advice. [...] It is current only as of the date listed on the Drug Formulary, and is not …

Saskatchewan Cancer Agency Saskatchewan Cancer Agency Drug Formulary User’s Guide
May 2021 Drug Formulary User’s Guide Saskatchewan Cancer Agency Drug Formulary …